A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

HomeTagsMerakris Therapeutics

Merakris Therapeutics

Merakris Therapeutics Announces the Commercial Launch of Dermacyte® Matrix and CMS Assignment of an HCPCS Code for Use as a Skin Graft Substitute

This is another milestone for Merakris Therapeutics that the largest healthcare payer, CMS, has recognized Dermacyte Matrix with a unique reimbursement code.
Spot_ImgSpot_Img

By using this website you agree to accept Medical Device News Magazine Privacy Policy